Chaudhary L R, Stocco D M
Department of Biochemistry, Texas Tech University Health Sciences Center, Lubbock 79430.
Biochem Int. 1989 Jan;18(1):251-62.
In this study we attempted to examine the effects of ketoconazole on steroid biosynthesis and to determine which steps in the steroidogenic pathway were blocked using MA-10 Mouse Leydig tumor cells. This cloned cell line produces progesterone as the major steroid following stimulation by hCG or dbcAMP. At a concentration of 1 microM ketoconazole completely inhibited the hCG- and dbcAMP-stimulated progesterone synthesis in MA-10 Leydig cells. The conversion of 25-hydroxycholesterol and 22R-hydroxycholesterol into progesterone was also suppressed by this drug. The presence of ketoconazole inhibited mitochondrial steroid synthesis but required high concentrations of the drug as compared to inhibition in intact cells. No accumulation of pregnenolone was observed in the presence of ketoconazole indicating that the activity of 3 beta-hydroxysteroid dehydrogenase was not affected. We conclude that ketoconazole directly inhibits the activity of cholesterol side-chain cleavage enzyme (CSCC), a rate-determining enzymatic step in steroidogenesis, by interacting with cytochrome P-450scc.
在本研究中,我们试图使用MA-10小鼠睾丸间质细胞瘤细胞来检测酮康唑对类固醇生物合成的影响,并确定类固醇生成途径中的哪些步骤被阻断。该克隆细胞系在人绒毛膜促性腺激素(hCG)或二丁酰环磷腺苷(dbcAMP)刺激后,产生孕酮作为主要类固醇。在1微摩尔浓度下,酮康唑完全抑制了MA-10睾丸间质细胞中hCG和dbcAMP刺激的孕酮合成。该药物还抑制了25-羟基胆固醇和22R-羟基胆固醇向孕酮的转化。酮康唑的存在抑制了线粒体类固醇合成,但与完整细胞中的抑制相比,需要高浓度的药物。在酮康唑存在下未观察到孕烯醇酮的积累,表明3β-羟基类固醇脱氢酶的活性未受影响。我们得出结论,酮康唑通过与细胞色素P-450scc相互作用,直接抑制胆固醇侧链裂解酶(CSCC)的活性,这是类固醇生成中的一个限速酶步骤。